Literature DB >> 33359432

Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals.

Renyi Wu1, Shanyi Li1, Rasika Hudlikar1, Lujing Wang1, Ahmad Shannar1, Rebecca Peter1, Pochung Jordan Chou1, Hsiao-Chen Dina Kuo1, Zhigang Liu1, Ah-Ng Kong2.   

Abstract

Biological redox signaling plays an important role in many diseases. Redox signaling involves reductive and oxidative mechanisms. Oxidative stress occurs when reductive mechanism underwhelms oxidative challenges. Cellular oxidative stress occurs when reactive oxygen/nitrogen species (RO/NS) exceed the cellular reductive/antioxidant capacity. Endogenously produced RO/NS from mitochondrial metabolic citric-acid-cycle coupled with electron-transport-chain or exogenous stimuli trigger cellular signaling events leading to homeostatic response or pathological damage. Recent evidence suggests that RO/NS also modulate epigenetic machinery driving gene expression. RO/NS affect DNA methylation/demethylation, histone acetylation/deacetylation or histone methylation/demethylation. Many health beneficial phytochemicals possess redox capability that counteract RO/NS either by directly scavenging the radicals or via inductive mechanism of cellular defense antioxidant/reductive enzymes. Amazingly, these phytochemicals also possess epigenetic modifying ability. This review summarizes the latest advances on the interactions between redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals and the future challenges of integrating these events in human health.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Citric acid cycle; Epigenetics; Metabolism; Oxidative stress; Redox; Redox active phytochemicals

Mesh:

Substances:

Year:  2020        PMID: 33359432      PMCID: PMC8222414          DOI: 10.1016/j.freeradbiomed.2020.12.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  114 in total

1.  Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.

Authors:  Changjiang Xu; Guoxiang Shen; Chi Chen; Céline Gélinas; Ah-Ng Tony Kong
Journal:  Oncogene       Date:  2005-06-30       Impact factor: 9.867

2.  Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.

Authors:  David Cheng; Wenji Li; Lujing Wang; Tiffany Lin; George Poiani; Andrew Wassef; Rasika Hudlikar; Patricia Ondar; Luigi Brunetti; Ah-Ng Kong
Journal:  Mol Pharm       Date:  2019-03-28       Impact factor: 4.939

3.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

4.  Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.

Authors:  Kyung-Chul Choi; Myung Gu Jung; Yoo-Hyun Lee; Joo Chun Yoon; Seung Hyun Kwon; Hee-Bum Kang; Mi-Jeong Kim; Jeong-Heon Cha; Young Jun Kim; Woo Jin Jun; Jae Myun Lee; Ho-Geun Yoon
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 5.  An Overview of Chromatin-Regulating Proteins in Cells.

Authors:  Pingyu Zhang; Keila Torres; Xiuping Liu; Chang-Gong Liu; Raphael E Pollock
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

Review 6.  β-hydroxybutyrate: much more than a metabolite.

Authors:  John C Newman; Eric Verdin
Journal:  Diabetes Res Clin Pract       Date:  2014-08-19       Impact factor: 5.602

7.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells.

Authors:  Praveen Rajendran; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Clin Epigenetics       Date:  2011-10-26       Impact factor: 6.551

Review 8.  Acetyl-CoA and the regulation of metabolism: mechanisms and consequences.

Authors:  Lei Shi; Benjamin P Tu
Journal:  Curr Opin Cell Biol       Date:  2015-02-20       Impact factor: 8.382

9.  Oxidative stress alters global histone modification and DNA methylation.

Authors:  Yingmei Niu; Thomas L DesMarais; Zhaohui Tong; Yixin Yao; Max Costa
Journal:  Free Radic Biol Med       Date:  2015-02-03       Impact factor: 7.376

10.  Curcumin-Induced DNA Demethylation in Human Gastric Cancer Cells Is Mediated by the DNA-Damage Response Pathway.

Authors:  Ruiying Tong; Xian Wu; Ying Liu; Yang Liu; Jigang Zhou; Xinying Jiang; Li Zhang; Xiaoying He; Libing Ma
Journal:  Oxid Med Cell Longev       Date:  2020-06-17       Impact factor: 6.543

View more
  4 in total

1.  Tobacco carcinogen 4-[methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with diallyl sulphide (DAS).

Authors:  Rasika R Hudlikar; Davit Sargsyan; David Cheng; Hsiao-Chen Dina Kuo; Renyi Wu; Xiaoyang Su; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2022-03-24       Impact factor: 4.944

Review 2.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

3.  Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.

Authors:  Lujing Wang; Ahmad Abdel Fat Shannar; Renyi Wu; Pochung Chou; Md Shahid Sarwar; Hsiao-Chen Kuo; Rebecca Mary Peter; Yujue Wang; Xiaoyang Su; Ah-Ng Kong
Journal:  Mol Nutr Food Res       Date:  2022-04-28       Impact factor: 6.575

4.  Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.

Authors:  Shanyi Li; Renyi Wu; Lujing Wang; Hsiao-Chen Dina Kuo; Davit Sargsyan; Xi Zheng; Yujue Wang; Xiaoyang Su; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2021-11-02       Impact factor: 4.784

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.